These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20610624)

  • 1. miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer.
    Yu S; Lu Z; Liu C; Meng Y; Ma Y; Zhao W; Liu J; Yu J; Chen J
    Cancer Res; 2010 Jul; 70(14):6015-25. PubMed ID: 20610624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-21/RASA1 axis affects malignancy of colon cancer cells via RAS pathways.
    Gong B; Liu WW; Nie WJ; Li DF; Xie ZJ; Liu C; Liu YH; Mei P; Li ZJ
    World J Gastroenterol; 2015 Feb; 21(5):1488-97. PubMed ID: 25663768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers.
    Wolfe AR; Feng H; Zuniga O; Rodrigues H; Eldridge DE; Yang L; Shen C; Williams TM
    Cancer Lett; 2024 Jun; 591():216873. PubMed ID: 38604313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pancreatic cancer growth by superoxide.
    Du J; Nelson ES; Simons AL; Olney KE; Moser JC; Schrock HE; Wagner BA; Buettner GR; Smith BJ; Teoh ML; Tsao MS; Cullen JJ
    Mol Carcinog; 2013 Jul; 52(7):555-67. PubMed ID: 22392697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of KRAS Gene Expression and LCS6 Variant in Genomic and Cell-Free DNA of Iranian Women With Endometriosis.
    Farahani MS; Shahbazi S; Moghaddam SA; Mahdian R
    Reprod Sci; 2015 Jun; 22(6):679-84. PubMed ID: 25361550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RAS oncogene in brain tumors and the involvement of let-7 microRNA.
    Messina S
    Mol Biol Rep; 2024 Apr; 51(1):531. PubMed ID: 38637419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A polymorphism in a let-7 microRNA binding site of KRAS in women with endometriosis.
    Grechukhina O; Petracco R; Popkhadze S; Massasa E; Paranjape T; Chan E; Flores I; Weidhaas JB; Taylor HS
    EMBO Mol Med; 2012 Mar; 4(3):206-17. PubMed ID: 22307873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
    Valencia K; Erice O; Kostyrko K; Hausmann S; Guruceaga E; Tathireddy A; Flores NM; Sayles LC; Lee AG; Fragoso R; Sun TQ; Vallejo A; Roman M; Entrialgo-Cadierno R; Migueliz I; Razquin N; Fortes P; Lecanda F; Lu J; Ponz-Sarvise M; Chen CZ; Mazur PK; Sweet-Cordero EA; Vicent S
    J Clin Invest; 2020 Apr; 130(4):1879-1895. PubMed ID: 31874105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS regulation of miRNA: Stepping on the brake to go faster.
    Stalnecker CA; Der CJ
    Mol Cell; 2023 Jul; 83(14):2390-2392. PubMed ID: 37478822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS.
    Zhao WG; Yu SN; Lu ZH; Ma YH; Gu YM; Chen J
    Carcinogenesis; 2010 Oct; 31(10):1726-33. PubMed ID: 20675343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes.
    Keklikoglou I; Hosaka K; Bender C; Bott A; Koerner C; Mitra D; Will R; Woerner A; Muenstermann E; Wilhelm H; Cao Y; Wiemann S
    Oncogene; 2015 Sep; 34(37):4867-78. PubMed ID: 25500542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
    Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
    Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients.
    Zou Y; Li J; Chen Z; Li X; Zheng S; Yi D; Zhong A; Chen J
    Carcinogenesis; 2015 Jun; 36(6):676-84. PubMed ID: 25863127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HERG1 functions as an oncogene in pancreatic cancer and is downregulated by miR-96.
    Feng J; Yu J; Pan X; Li Z; Chen Z; Zhang W; Wang B; Yang L; Xu H; Zhang G; Xu Z
    Oncotarget; 2014 Jul; 5(14):5832-44. PubMed ID: 25071021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis.
    Kadera BE; Li L; Toste PA; Wu N; Adams C; Dawson DW; Donahue TR
    PLoS One; 2013; 8(8):e71978. PubMed ID: 23991015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genome-wide investigation of microRNA expression identifies biologically-meaningful microRNAs that distinguish between high-risk and low-risk intraductal papillary mucinous neoplasms of the pancreas.
    Permuth-Wey J; Chen YA; Fisher K; McCarthy S; Qu X; Lloyd MC; Kasprzak A; Fournier M; Williams VL; Ghia KM; Yoder SJ; Hall L; Georgeades C; Olaoye F; Husain K; Springett GM; Chen DT; Yeatman T; Centeno BA; Klapman J; Coppola D; Malafa M
    PLoS One; 2015; 10(1):e0116869. PubMed ID: 25607660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-gene signaling pathways in pancreatic cancer.
    Drakaki A; Iliopoulos D
    Biomed J; 2013; 36(5):200-8. PubMed ID: 24225187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-210 regulates the interaction between pancreatic cancer cells and stellate cells.
    Takikawa T; Masamune A; Hamada S; Nakano E; Yoshida N; Shimosegawa T
    Biochem Biophys Res Commun; 2013 Aug; 437(3):433-9. PubMed ID: 23831622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting miR-21 for the therapy of pancreatic cancer.
    Sicard F; Gayral M; Lulka H; Buscail L; Cordelier P
    Mol Ther; 2013 May; 21(5):986-94. PubMed ID: 23481326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.